EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 7 filers reported holding EXELIXIS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 11.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,802 | -34.9% | 2,920 | -43.0% | 0.06% | -29.8% |
| Q2 2023 | $97,939 | -1.5% | 5,125 | 0.0% | 0.08% | -17.6% |
| Q1 2023 | $99,476 | +21.0% | 5,125 | 0.0% | 0.10% | +37.8% |
| Q4 2022 | $82,205 | +2.8% | 5,125 | 0.0% | 0.07% | -1.3% |
| Q3 2022 | $80,000 | +19.4% | 5,125 | +60.2% | 0.08% | +29.3% |
| Q2 2022 | $67,000 | -8.2% | 3,200 | 0.0% | 0.06% | +16.0% |
| Q1 2022 | $73,000 | +25.9% | 3,200 | 0.0% | 0.05% | +42.9% |
| Q4 2021 | $58,000 | -14.7% | 3,200 | 0.0% | 0.04% | -18.6% |
| Q3 2021 | $68,000 | +17.2% | 3,200 | 0.0% | 0.04% | +13.2% |
| Q2 2021 | $58,000 | -38.9% | 3,200 | -23.8% | 0.04% | -42.4% |
| Q1 2021 | $95,000 | +13.1% | 4,200 | 0.0% | 0.07% | +3.1% |
| Q4 2020 | $84,000 | -18.4% | 4,200 | 0.0% | 0.06% | -29.7% |
| Q3 2020 | $103,000 | +119.1% | 4,200 | +110.0% | 0.09% | +97.8% |
| Q2 2020 | $47,000 | -77.7% | 2,000 | -81.4% | 0.05% | -83.2% |
| Q4 2018 | $211,000 | – | 10,725 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |